BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10581153)

  • 1. Conversion of a guanylyl cyclase to an adenylyl cyclase.
    Beuve A
    Methods; 1999 Dec; 19(4):545-50. PubMed ID: 10581153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrphostins are inhibitors of guanylyl and adenylyl cyclases.
    Jaleel M; Shenoy AR; Visweswariah SS
    Biochemistry; 2004 Jun; 43(25):8247-55. PubMed ID: 15209521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A.
    Joubert S; McNicoll N; De Léan A
    Biochem Pharmacol; 2007 Apr; 73(7):954-63. PubMed ID: 17196175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional chimera of mammalian guanylyl and adenylyl cyclases.
    Weitmann S; Würsig N; Navarro JM; Kleuss C
    Biochemistry; 1999 Mar; 38(11):3409-13. PubMed ID: 10079086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate selection by class III adenylyl cyclases and guanylyl cyclases.
    Linder JU
    IUBMB Life; 2005 Dec; 57(12):797-803. PubMed ID: 16393782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural basis for the role of nucleotide specifying residues in regulating the oligomerization of the Rv1625c adenylyl cyclase from M. tuberculosis.
    Ketkar AD; Shenoy AR; Ramagopal UA; Visweswariah SS; Suguna K
    J Mol Biol; 2006 Mar; 356(4):904-16. PubMed ID: 16403515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine nucleotide cyclases in the malaria parasite.
    Baker DA; Kelly JM
    Trends Parasitol; 2004 May; 20(5):227-32. PubMed ID: 15105023
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
    Lamothe M; Chang FJ; Balashova N; Shirokov R; Beuve A
    Biochemistry; 2004 Mar; 43(11):3039-48. PubMed ID: 15023055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant negative mutants of guanylyl cyclase: probes for global functions and intramolecular mechanisms.
    Yuen PS
    Methods; 1999 Dec; 19(4):532-44. PubMed ID: 10581152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis.
    Liu Y; Ruoho AE; Rao VD; Hurley JH
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13414-9. PubMed ID: 9391039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional chimeras between the catalytic domains of the mycobacterial adenylyl cyclase Rv1625c and a Paramecium guanylyl cyclase.
    Linder JU; Castro LI; Guo YL; Schultz JE
    FEBS Lett; 2004 Jun; 568(1-3):151-4. PubMed ID: 15196937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate guanylyl cyclases: multiple mechanisms of activation.
    Kobiałka M; Gorczyca WA
    Acta Biochim Pol; 2000; 47(3):517-28. PubMed ID: 11310956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases.
    Sunahara RK; Beuve A; Tesmer JJ; Sprang SR; Garbers DL; Gilman AG
    J Biol Chem; 1998 Jun; 273(26):16332-8. PubMed ID: 9632695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, function and evolution of microbial adenylyl and guanylyl cyclases.
    Baker DA; Kelly JM
    Mol Microbiol; 2004 Jun; 52(5):1229-42. PubMed ID: 15165228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.
    Gupta G; Azam M; Yang L; Danziger RS
    J Clin Invest; 1997 Sep; 100(6):1488-92. PubMed ID: 9294115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial adenylyl cyclases: biochemical diversity and structural plasticity.
    Shenoy AR; Visweswariah SS
    FEBS Lett; 2006 Jun; 580(14):3344-52. PubMed ID: 16730005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity determinants of class III nucleotidyl cyclases.
    Bharambe NG; Barathy DV; Syed W; Visweswariah SS; Colaςo M; Misquith S; Suguna K
    FEBS J; 2016 Oct; 283(20):3723-3738. PubMed ID: 27542992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of residues crucially involved in soluble guanylate cyclase activation.
    Rothkegel C; Schmidt PM; Stoll F; Schröder H; Schmidt HH; Stasch JP
    FEBS Lett; 2006 Jul; 580(17):4205-13. PubMed ID: 16831427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylyl cyclase Rv0386 from Mycobacterium tuberculosis H37Rv uses a novel mode for substrate selection.
    Castro LI; Hermsen C; Schultz JE; Linder JU
    FEBS J; 2005 Jun; 272(12):3085-92. PubMed ID: 15955067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying the structure and regulation of soluble guanylyl cyclase.
    Koesling D
    Methods; 1999 Dec; 19(4):485-93. PubMed ID: 10581148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.